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IgA nephropathy is the most common form of progressive
glomerulonephritis although the pathophysiology of this
nephropathy is unclear. The ddY mouse is a spontaneous
animal model with variable incidence and extent of
glomerular injury mimicking human IgA nephropathy. Here,
we transplanted bone marrow cells from 20-week-old ddY
mice with beginning or quiescent IgA nephropathy into
irradiated similar ddY mice, C57Bl/6 (Th1 prone) mice, or
BALB/c (Th2 prone) mice. Serum IgA/IgG complex and
Th1/Th2 polarization of spleen cells was determined by
enzyme-linked immunosorbent assay and confirmed by
fluorescent cytometric analysis. The ddY mice with
commencing IgA nephropathy demonstrated strong
polarization toward Th1, while those with quiescent disease
were Th2 polarized. Serum levels of IgA/IgG2a immune
complex significantly correlated with the severity of the
glomerular lesions. Bone marrow taken from mice with
commencing IgA nephropathy conferred IgA nephropathy
with Th1 polarization in recipient-quiescent mice, while
transplantation from the quiescent mice ablated glomerular
injury and mesangial IgA/IgG deposition in those
commencing IgA disease. However, adoptive transfer of
CD4þ T cells from those whose disease began failed to
induce any IgA deposition or renal injury. Our study suggests
that bone marrow cells, presuming IgA producing cells, may
initiate this disease. Th1 cells may be involved in the
pathophysiology of the disease after glomerular IgA
deposition.
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IgA nephropathy (IgAN) is the commonest form of
progressive primary glomerulonephritis, exhibiting mesan-
gial IgA and IgG co-deposition.1 Although the pathogenesis
of IgAN remains unclear, many studies convincingly suggest
the involvement of dysregulation of the immune system.2,3
Fundamental pathogenic factors may underlie outside of the
kidney, because half of IgAN patients show recurrences after
renal transplantation.4
A previous report demonstrated that in a patient with
IgAN and chronic myeloblastic leukemia, bone marrow
transplantation (BMT) resulted not only in remission of
leukemia but also in IgAN.5 In addition, Imasawa et al.6
reported that BMT from normal mice attenuated glomerular
lesion in a murine model of IgAN, HIGA (high serum IgA
ddY) mice, while the glomerular lesion associated with IgA
deposition was reconstituted in normal recipient mice after
BMT from HIGA mice. The above background indicates that
IgAN may involve disorders of stem cells.
Other studies discussed that functional abnormalities of
B- and/or T cells may underlie in the pathogenesis of IgAN.
Emerging evidence indicates the involvement of aberrantly
glycosylated IgA1 in the pathogenesis.7,8 Furthermore, Allen
et al.9 reported B-cell-restricted reduction of b 1,3 galacto-
syltransferase activity (responsible for the aberrant O-
glycosylated serum IgA1). Of note, recent study reported
that Th2 cytokines induced altered IgA glycosylation,
presumably via reduction of b 1,3 galactosyltransferase
enzymatic activity.10 Moreover, in experimental IgAN, Th2
cytokines may alter the glycosylation of IgA produced by B
cells,11 although the molecular structure of murine IgA is
different from that of human IgA1. Indeed, Th1/Th2
imbalance is expected to have an important role in this
disease.12 Many studies have found that the principal
cytokines produced by circulating T cells in IgAN are Th2
type.13,14 However, some other reports indicated Th1
predominance in IgAN,15,16 emphasizing that the pathogenic
importance of Th1/Th2 polarization in this disease remains
unclear.
The ddY mice are known as a spontaneous murine IgAN
model, but the incidence of IgAN is highly variable. Indeed,
although HIGA mice show high serum levels of IgA, serum
IgA levels are not associated with the severity of glomerular
injury and incidence of the disease. We recently found that
the ddY mice could be classified into three groups, the early
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onset (B20 weeks), late onset (B40 weeks), and quiescent
groups by serial biopsies that confirm the glomerular lesions
and IgA deposition.17 A genome-wide association study of
the early onset and the quiescent mice revealed that the
susceptibility to murine IgAN is partly regulated by specific
loci syntenic to the IGAN1 gene18 known as a candidate gene
of human familial IgAN.17 Those results suggested suitability
of the grouped ddY mice model for examining the
pathogenesis of IgAN. Although administration of Th1
cytokines could induce crescentic glomerular lesions in
HIGA mice,19 it remains unclear whether Th-dependent
immune regulation is specifically involved in the onset of
IgAN.
This study with the grouped ddY mouse model aimed to
examine the role of bone marrow-derived cells (BMC) in the
induction and Th polarity of this disease and approach the
potential mechanisms.
RESULTS
The murine IgAN is linked to Th1 polarity
We first examined the production of interferon (IFN)-g and
interleukin (IL)-4, which are representative cytokines of Th1
and Th2, respectively, in spleen cells of C57Bl/6 (B6) and
BALB/C (BALB) mice (each n¼ 5). Spleen cells of B6 and
BALB mainly produced IFN-g and IL-4, respectively. These
findings are compatible with previous reports,20 suggesting
that major cells producing these cytokines may be CD4þ T
cells. Next, we investigated these cytokines production in the
IgAN-onset and the quiescent ddY mice (each n¼ 5).
Although the levels of IFN-g and IL-4 produced by cultured
splenic cells were stable between 20 and 40 weeks of age in the
quiescent group, the levels of IFN-g were higher and those of
IL-4 were lower in the onset mice than those of the quiescent
mice at 20 and 40 weeks of age (Po0.01, each, Figure 1a).
Furthermore, in the onset group, the level of IFN-g at 40
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Figure 1 | Production of Th1/Th2 cytokines by splenic T cells. (a) Th1- and Th2-prone mice, B6 and BALB, show Th1- and Th2-dominant
immune regulation, respectively. Although the levels of IFN-g and IL-4 remained stable in the quiescent mice from 20 to 40 weeks of age, the
onset mice showed significantly higher levels of IFN-g and lower levels of IL-4 than those of the quiescent mice at 20 and 40 weeks of age
(Po0.01). Furthermore, the levels of IFN-g in the onset mice increased from 20 to 40 weeks of age (Po0.01). (b) To further confirm Th1
polarization in the onset mice, we checked intracellular IFN-g production in CD4þ T cells by FACS. CD4þ T cells from the onset mice showed
higher amounts of intracellular IFN-g, suggesting strong Th1 polarization. Meanwhile, Th1 polarization is not shown in the quiescent mice; data
are mean7s.d.
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weeks of age was higher than that at 20 weeks (Po0.01,
Figure 1a). To further confirm Th1 polarization in the onset
ddY mice, intracellular IFN-g produced by CD4þ T cells
were analyzed using flow cytometric analysis (FACS). The
FACS analysis showed that CD4þ T cells strongly expressed
IFN-g in the onset mice, but not in the quiescent mice
(Figure 1b).
Serum IgA–IgG2a immune complex levels correlate with
severity of glomerular lesions
Immunohistological analyses showed that most of glomerular
IgA was colocalized with IgG (Figure 2a), especially IgG2a
(Figure 2b and c) in the onset group. Interestingly, IgA
formed an immune complex (IC) with IgG2a in the sera of
these mice, and the serum levels of this complex were higher
in the onset group than the quiescent group (P¼ 0.0031,
Figure 3a, each n¼ 30). Moreover, serum levels of IgA–IgG2a
IC correlated with the severity of glomerular injury
(Po0.0001, Figure 3b).
Murine IgAN is reconstituted in the quiescent mice by
BMC from the onset mice
To verify that IgAN is directed by BMC, we conducted three
different BMT (the onset mice to the quiescent mice, the onset
mice to the onset mice, and the quiescent mice to the onset
mice; n¼ 5 for each BMT). BMT from the onset mice induced
glomerular injury and mesangial IgA/IgG deposition with
progression of albuminuria in the quiescent recipients (Figure
4a and d). BMT from the onset mice accelerated the
glomerular injury and albuminuria in the recipient-onset mice
(Figure 4b and d). Conversely, BMT from the quiescent mice
improved not only glomerular injury and mesangial IgA/IgG
deposition but also albuminuria in the recipient-onset mice
(Figure 4c and d). These results are summarized in Table 1.
BMT from the onset mice resulted in Th1 polarization
and a rise in serum IgA–IgG2a IC in recipient-normal mice
Next, we examined Th polarization after BMT. BMT (from
the onset mice to the quiescent mice) resulted in increase in
IFN-g (Po0.01) and decrease in IL-4 production by spleen
cells (Po0.01, Figure 5a, n¼ 5). FACS analysis for the
intracellular cytokine production revealed strong IFN-g
expression in CD4þ T cells in the transplanted normal mice
(Figure 5b), further confirming Th1 polarization with
glomerular injury. Moreover, BMT from the onset mice
further increased the level of IFN-g in recipient-onset mice
(Po0.001, Figure 5a, n¼ 5). Importantly, serum levels of
IgA–IgG2a IC were increased after BMT from the onset mice
to both the quiescent (Po0.01) and the onset mice (Po0.05)
(Figure 5c), although total serum levels of IgA, IgG, and IgM
did not change significantly (Figure 5d). In contrast, a
significant decrease in IFN-g and increase in IL-4 were found
after BMT from the quiescent mice in recipient-onset mice
(Po0.01, Figure 5a, n¼ 5) with improvement of glomerular
injury and marked decrease in serum levels of IgA–IgG2a IC
(Po0.05) (Figure 5c).
Adoptive transfer of CD4þ T cells failed to induce murine
IgA nephropathy
To further investigate whether CD4þ T cells directly regulate
the production of nephritogenic IgA production and thus
induce this disease, CD4þ T cells from the onset mice were
adoptively transferred into BALB/cAJcl-nu/nu (nude) mice
with or without serum from the onset mice. However, the
CD4þ T cells could not induce any renal injuries or IgA
deposition in any cases.
DISCUSSION
In this study, we showed that systemic immune response in
ddY mice with IgAN was strongly polarized toward Th1,
which could be reconstituted in the quiescent and normal
control mice by BMC from the onset mice. IFN-g production
by splenic T cells in the onset mice increased significantly
from 20 to 40 weeks of age with progression of glomerular
injury, and the severity was correlated with Th1 phenotypes.
Although the pathogenic importance of Th1/Th2 polar-
ization in this disease remains unclear,12–16 IgA production is
critically driven by IL-5, a Th2 cytokine.21 There is also
evidence that Th2 cytokines regulate IgA glycosylation, partly
via inactivation of b 1,3 galactosyltransferase.10 Although the
molecular structure of murine IgA differs from that of
human IgA1, severity of murine IgAN is associated with
abnormalities in IgA glycosylation in mice that have a
predominant Th2 response (BALB) compared with control
(C3HeB) mice.22 By using transgenic mice of GATA-3 known
as a key transcriptional factor of Th2, our recent study
demonstrated that Th2-predominant mucosal immune
responses are critical for glomerular IgA deposition (Yama-
naka et al. reported at the annual meeting of the American
Society of Nephrology, Philadelphia, PA, USA, 2005). These
findings indicate that Th2 predominance may influence
mucosal induction of IgA producing cells and thus
subsequent mesangial IgA deposition in this disease.23,24
This study showed that the quiescent mice are Th2 prone,
while the onset mice have strong Th1 polarity, suggesting that
both Th1 and Th2 polarities may contribute to different
processes of this disease, presumably induction and progres-
sion steps, respectively.
A previous BMT study using HIGA and B6 mice indicated
that BMC plays an important role in the pathogenesis of
murine IgAN.6 In this study, we also applied BMT in the
same strain of mice; the IgAN-onset and the quiescent ddY
mice. BMC from the quiescent mice abated not only
glomerular IgA deposition but also expansion of mesangial
matrix and proliferation of mesangial cells, indicating that
this improvement may be partly dependent on disappearance
of continuous delivery of nephritogenic IgA. Moreover, it is
possible that bone marrow-derived renal resident cells may
contribute to resolution of the matrix expansion after this
BMT, as reported previously.25 As shown in Figure 4b and d,
BMT from the onset mice accelerated the glomerular injury
and albuminuria in the recipient-onset mice. We may need to
consider the roles of regulatory T cells (Treg) to assess this
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Figure 2 | Immunostaining of IgA, IgG, and each IgG subclass in the IgAN-onset ddY mouse. (a) Glomerular IgA deposition was colocalized
with IgG. (b) Especially, IgG2a was well colocalized with IgA. Each original magnification is  400. (c) Glomerular IgA–IgG colocalization
was semi-quantitated. Glomerular IgA was well colocalized with IgG2a, followed by IgG1, IgG3, and IgG2b. Data are mean7s.d.
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result. Treg play a suppressive role in many autoimmune
diseases and can potentially affect various steps in the
progression of disease.26–28 Importantly, the balance between
Treg and Th1 effector T cells is important in determining the
outcome of disease development.29,30 Indeed, some IgAN-
onset mice showed rapid progression like the recipient-onset
mice transplanted from the onset mice (data are not shown).
Since Treg accumulated in secondary lymph nodes31 might
be depleted by total body irradiation in recipient-onset mice,
Th1 effector function might be enhanced. In results,
dramatically increased Th1 cytokine might accelerate pro-
gression of renal injuries. It is our urgent task to investigate
how Treg regulate the murine IgAN for this hypothesis.
Although the reconstituted IgAN by BMT was accom-
panied with Th1 polarization, it is still unclear whether Th1
polarization is causal or resultant of renal injuries. Dendritic
cells are unique bone marrow-derived antigen-presenting
cells that play a key role in the initiation and modulation of
immune responses. They also regulate CD4þ T-cell priming
and thus Th1/Th2 polarization.32,33 Previous studies postu-
lated that microbial antigens are involved in the pathogenesis
of IgAN,34,35 partly via dendritic cells function.36 However,
since all BMT in our study were performed under specific
pathogen-free conditions, environmental factors such as
additional exogenous microbial antigens could be neglected
in the reconstitution after BMT. To examine whether CD4þ
T cells regulate the IgA production, CD4þ T cells from the
onset mice were adoptively transferred into nude mice. We
also injected serum from the onset mice to exclude the
possibilities that serum protein such as IgA–IgG2a IC is
required for T- or B-cell functions. However, no mice showed
any glomerular IgA deposition or renal injuries. Accordingly,
bone marrow may include B-cell lineages that independently
of CD4þ T cells and continuously provide the nephritogenic
IgA. Indeed, abnormal IgA1 in human IgAN is considered to
be produced in bone marrow.37,38 Moreover, our group
recently reported that BMT from the onset mice into
alymphoplasia mutant mice (aly/aly) lack all systemic lymph
nodes, Payer’s patch, and serum IgA-reconstituted glomeru-
lar IgA deposition, but not disease progression and Th1
polarization (Aizawa M et al. reported at the annual meeting
of American Society of Nephrology, San Diego, CA, USA,
2006). These uncoupling data suggest that Th1 polarization
may require secondary lymphoid tissues after the IgA
deposition. Interestingly, serum levels of IgA–IgG2a IC
correlated with the severity of renal injury in this disease.
In rodents, it is known that deposition of antigen-specific
IgG2a and glomerular IgG2a is linked to Th1-dominant
immune regulation.39,40 Although the underlying mechan-
isms for the formation of IgA–IgG2a IC and following
glomerular deposition are still unclear, there is ample
evidence for the presence of abnormal IgA in complexes
with IgG even in IgAN patients.41–45 In addition, it is
noteworthy that human IgAN was originally described by
Berger and Hinglais1 as ‘nephropathy with mesangial
IgA–IgG co-deposits’. These reports suggest that IgA–IgG IC
formation may be partly due to antigen–antibody interaction
with altered IgA1 as the antigen.45,46 Importantly, Tomana
et al.45 reported that the antibody subtype to the altered IgA1
in human IgAN was predominantly IgG2.
This study demonstrated that progression of murine IgAN
is linked to systemic Th1 immune response accompanied by
elevation of serum IgA–IgG2a IC levels. This polarization
might be indirectly regulated by bone marrow-derived
nephritogenic B cells followed by priming of CD4þ T cells.
To design new therapeutic strategies for IgAN, additional
studies using this model are required to identify the
responsible cell types and define the exact underlying
mechanisms.
MATERIALS AND METHODS
Mice
Female ddY mice (SLC Japan, Shizuoka, Japan) were maintained at
the animal facility of Juntendo University and provided with regular
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Figure 3 | Serum levels of IgA/IgG IC. (a) Serum levels of each IgA–IgG IC were expressed by relative value to those of BALB. Serum levels
of IgA–IgG2a complex in the IgAN-onset ddY mice (n¼ 30) were significantly higher than those in the quiescent mice (n¼ 30) (P¼ 0.0031).
Data are mean7s.d. (b) Serum levels of IgA–IgG2a complex correlated with the severity of glomerular injury (Po0.0001).
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chow (MF; Oriental Yeast, Tokyo, Japan) in a specific pathogen-free
room. The original ddY mice were maintained as outbreed animal
and thus genetically heterogeneous. However, we evaluated their
renal histology by serial renal biopsies and found that they were in
three different groups dependent on the renal injuries.17 The ddY
mice at 20 weeks of age were divided into two groups, the
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Figure 4 | BMC are responsible for the induction of IgAN. (a–c) Renal pathology. (a) BMT from the onset mice resulted in
mesangioproliferative glomerular injury with mesangial deposition of IgA and IgG in the quiescent recipients. (b) BMT from the onset mice
accelerated the progression of glomerular injury with IgA and IgG deposition in the onset mice. (c) In contrast, BMT from quiescent mice
resulted in reduction of not only glomerular injury but also mesangial deposition of IgA and IgG in the recipient-onset mice. Each original
magnification is  400. (d) Urinary albumin levels. BMT from the onset mice caused progression of albuminuria in the recipient-quiescent mice.
BMT from the onset mice caused marked enhancement of albuminuria in the recipient-onset mice. Conversely, levels of albuminuria were
decreased in recipient-onset mice after BMT from the quiescent mice. Data are mean7s.d.
Table 1 | Features of the IgAN onset and the quiescent mice and summary of results from BMT studies using those mice
Bone marrow transplantation Kidney Serum Systemic
Donor Recipient
Glomerular
injury IgA
deposition
Mesangial
co-deposition IgA–IgG
IgA–IgG2a IC
level IgA level IgG level Th1 polarity
IgAN onset Quiescent + + + m - - m
Quiescent IgAN onset k k k k - - –
IgAN onset IgAN onset ++ ++ ++ mm - - mm
IgAN onset mice – + + + m - - m
Quiescent mice – – – – - - - –
BMT, bone marrow transplantation; IgAN, IgA nephropathy.
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IgAN-onset and the quiescent groups by semi-quantitative analysis
of biopsy specimens, as described previously by our group.17 Same-
age female BALB/c (BALB) and C57Bl/6 (B6) mice were used for
control. Female BALB/cAJcl-nu/nu (nude) mice were used for
adoptive transfer from the onset ddY mice. The experimental
protocol was approved by the Ethics Review Committee for Animal
Experimentation of Juntendo University School of Medicine.
Histological examination of renal tissues
For light microscopy, the renal specimens were fixed in 10% neutral
phosphate-buffered formalin, embedded in paraffin, and sliced at
2 mm thickness. The slices were stained with hematoxylin and eosin,
periodic acid-Schiff, and Azan. Snap frozen 4-mm thick renal
sections were used for immunofluorescence with fluorescein
isothiocyanate-conjugated goat anti-mouse IgA (BD Biosciences,
San Diego, CA, USA; Pharmingen, San Diego, CA, USA) and
rhodamine-conjugated goat anti-mouse IgG antisera (Cappel
Research Reagents, Costa Mesa, CA, USA). For analysis of IgG
subclasses, we used fluorescein isothiocyanate-conjugated rat anti-
mouse IgG1, IgG2a, IgG2b, IgG3 (BD Biosciences, Pharmingen),
and rhodamine-conjugated goat anti-mouse IgA antisera (Santa
Cruz Biotechnology, Santa Cruz, CA, USA).
Semi-quantitative analysis of biopsy specimens
Renal injuries in the biopsy specimens were scored in a triple-blind
manner by two nephrologists and one pathologist. Biopsy specimens
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Figure 5 | BMT reconstituted IgAN with Th1 phenotypes. (a) Levels of IFN-g increased and IL-4 levels decreased in recipient-quiescent mice
after BMT from the onset mice (Po0.01). After BMT from the onset mice, IFN-g levels further increased in recipient-onset mice (Po0.001).
Conversely, the splenic productions of IFN-g decreased and that of IL-4 increased in recipient-onset mice after BMT from the quiescent mice
(Po0.01). (b) FACS analysis for the intracellular cytokine production revealed strong IFN-g expression in CD4þ T cells in the transplanted
control mice from the onset mice. (c) Serum levels of IgA–IgG2a IC were expressed relative to those of BALB. BMT from the onset mice to both
the quiescent** and the onset mice* resulted in increase in serum IgA–IgG2a complex (*Po0.05 and **Po0.01, respectively), while those levels
were decreased after BMT from the quiescent to the onset mice. (d) Serum levels of IgA, IgG, and IgM did not change after each BMT. Data are
mean7s.d.
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that contained more than 10 glomeruli were used for histopatho-
logical analysis. All biopsy specimens were quantitatively analyzed to
determine the percentages of glomeruli with (a) segmental and
global sclerosis and/or (b) mesangial cell proliferation and/or
(c) increase in mesangial matrix. Each specimen was scored semi-
quantitatively for the percentages of the aforementioned lesioned
glomeruli (score 0¼ 0%, score 1¼ 1–24%, score 2¼ 25–49%, and
score 3X50% of all glomeruli).17,47,48 Total scores in each specimen
maximally became nine using our scoring system. We defined renal
injury as renal lesion whose histology score is more than the
meanþ 2 s.d. of the score in BALB mice. Since the average score in
BALB mice was 1.42470.969, cases whose histology scores are more
than four were regarded as renal injury in this study. For evaluation
of degree of IgA–IgG colocalization, 10 glomeruli on 10 biopsy
specimens from the onset mice were semi-quantitatively analyzed
(score 0¼ 0%, score 1¼ 1–24%, score 2¼ 25–49%, score
3¼ 50–75%, and score 4 X75% of all glomeruli).
Measurement of serum IgA–IgG IC and urinary albumin
excretion
Blood samples were obtained from the orbital venous plexus using
capillary tubes. Serum IgA–IgG IC concentrations were measured by
sandwich enzyme-linked immunosorbent assay. Enzyme-linked
immunosorbent assay plate was coated overnight with 5 mg/ml
purified rat anti-mouse IgG1, IgG2a, IgG2b, and IgG3 antisera (BD
Biosciences, Pharmingen) for overnight at 41C. Coated plates were
blocked with 2% bovine serum albumin in phosphate-buffered
saline, and duplicated serum samples were incubated overnight at
41C. After incubation with horseradish peroxidase-conjugated goat
anti-mouse IgA (ZYMED Laboratories, San Francisco, CA, USA),
for 3 h at room temperature, wells were developed with tetra-
methylbenzidine (TMB) substrate reagent set (BD Biosciences, San
Jose, CA, USA), and the absorbance was measured at 450 nm. Data
were expressed relatively to the value of BALB. Urinary albumin was
measured using an enzyme-linked immunosorbent assay kit
(Albuwell, Exocell, Philadelphia, PA, USA). Serum and urine
samples from BALB were used as control.
Bone marrow transplantation
The bone marrow was harvested from the tibia, femur, and humerus
under sterile conditions. Red blood cells were removed by ACK
lysing buffer (0.15 mol/l NH4Cl, 1.0 mmol/l KHCO3, and 0.1 mmol/l
Na2EDTA, pH 7.2) for 5 min at room temperature, and washed in
RPMI-1640 media supplemented with 1% fetal calf serum (FCS).
Recipient mice were exposed to 10 Gy total body irradiation to
deplete own BMC. To prevent the effect of irradiation on kidney, the
lower abdomen was covered with a lead protector. After total body
irradiation, 1 107 donor BMC were injected into the tail vein on
day 0. The resulting chimeric mice were housed under specific
pathogen-free conditions for 10 weeks to allow bone marrow
reconstitution. Environmental factors were not altered before and
after each BMT. Urinalysis was performed every week after BMT.
After 10 weeks from BMT, renal histology was analyzed and blood
samples were collected for measurement of immunoglobulin and
IgA–IgG2a IC.
Measurement of cytokines produced by splenic T cells
To assess the production of IFN-g and IL-4 by spleen cells, spleens
were removed from the mice. Spleen cell suspensions were prepared
by compression with the handle of a syringe in RPMI-1640 media
with 1% FCS followed by passage through a 100mm nylon mesh.
Red blood cells were removed by ACK lysing buffer (0.15 mol/l
NH4Cl, 1.0 mmol/l KHCO3, and 0.1 mmol/l Na2EDTA, pH 7.2) for
5 min at room temperature, and washed in RPMI-1640 media with
1% FCS. Spleen cells (1 106 cells/ml) were cultured in RPMI-1640
media with 10% FCS for 48 h at 371C. IFN-g and IL-4 were
measured using enzyme-linked immunosorbent assay kit (ENDO-
GEN, Pierce Biotechnology, Rockford, IL, USA). To further confirm
that CD4þ T cells in the diseased mice mainly produce IFN-g, we
analyzed intracellular IFN-g in CD4þ T cells by FACS. Splenic
CD4þ T cells were isolated by positive selection using anti-CD4
(L3T4) MicroBeads (MACSs, Miltenyi Biotec, Bergisch Gladbach,
Germany), according to the supplier’s instructions. Briefly, spleen cells
were resuspended at 1 107 cells/90ml and 10ml of anti-CD4 Micro-
Beads was added to cells for 15 min at 41C. Then, CD4þ T cells
were isolated by magnetic separation. CD4þ T cells (1 106/ml)
were analyzed for IFN-g production by intracellular staining. For
IFN-g staining, purified CD4þ T cells were cultured in RPMI-1640
media with 10% FCS, stimulated for 2 h with 1 mg/ml of ionomycin,
and 10 mg/ml Breferdin-A (Sigma-Aldrich, St Louis, MO, USA).
After permiabilizing (BD FACS Permeabilizing solution 2, BD
Biosciences), fluorescein isothiocyanate-conjugated rat anti-mouse
IFN-g, rat anti-mouse CD4-PerCP-Cy5.5 (BD PharmingenTM BD
Biosciences, San Jose, CA, USA) were used for staining. Samples
were acquired using an FACScan (BDISTM, BD Biosciences, San Jose,
CA, USA), and the data were analyzed by WinMDI (Windows
Multiple Document Interafce for Flow Cytometry).
Adoptive transfer of CD4T cells
CD4þ T cells (1 106) were isolated from the spleen of onset ddY
mice at 20 weeks of age using CD4 (L3T4) MicroBeads (MACSs).
Serum was also collected at the same time. CD4þ T cells with or
without serum and serum alone were injected into nude mice. The
serum (100 ml) was injected to each mouse once a week for three
times. After 3 weeks, renal specimens were histologically analyzed
for the induction of IgAN.
Statistical analysis
Correlations between the different parameters were analyzed by the
Student’s t-test. Analysis of variance was used to determine
differences in the characteristics among multiple groups. Data are
expressed as mean7s.d. or median values. Po0.05 were considered
significant. All statistical analyses were performed using the
Macintosh version of StatView 5.0 software (Abacus Concept Inc.,
Berkeley, CA, USA).
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